United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report Forecast 2017 to 2022

November 2017 | 121 pages | ID: U20E639C420EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Glucagon Like Peptide-1 (GLP-1) Agonists industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Glucagon Like Peptide-1 (GLP-1) Agonists market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
company 8
company 9

United States Glucagon Like Peptide-1 (GLP-1) Agonists Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Glucagon Like Peptide-1 (GLP-1) Agonists Market: Application Segment Analysis
Hospital
Pharmacy
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET OVERVIEW

1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation by Type
  1.2.1 United States Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Segmentation by Application
  1.3.1 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Market Share by Application in 2016
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Glucagon Like Peptide-1 (GLP-1) Agonists (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Production and Share by Manufacturers (2015 and 2016)
3.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Production Area and Product Type
3.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
  3.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate
  3.5.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Production and Market Share by Type (2012-2017)
4.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2012-2017)
4.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2012-2017)
4.4 United States Glucagon Like Peptide-1 (GLP-1) Agonists Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET ANALYSIS BY APPLICATION

5.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption and Market Share by Application (2012-2017)
5.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURERS ANALYSIS

6.1 Novo Nordisk
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 GSK
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Sanofi
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Bristol-Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Amylin
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 company
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST ANALYSIS

7.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2017-2022)

11.1 United States Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue Forecast (2017-2022)
11.2 United States Glucagon Like Peptide-1 (GLP-1) Agonists Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Glucagon Like Peptide-1 (GLP-1) Agonists Production Forecast by Type (2017-2022)
11.4 United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2017-2022)
11.5 Glucagon Like Peptide-1 (GLP-1) Agonists Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Classification of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure United States Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
Table Application of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure United States Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application in 2016
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate (2011-2021)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate (2011-2021)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales of Key Manufacturers (2015 and 2016)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Manufacturers
Figure 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Manufacturers
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Manufacturers (2015 and 2016)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table 2016 United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers
Table United States Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price of Key Manufacturers in 2015
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 3 Manufacturers
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Market Share of Top 5 Manufacturers
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Type (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2015
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate by Type (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2012-2017)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2016
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate by Application (2012-2017)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate by Application (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Amylin Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Glucagon Like Peptide-1 (GLP-1) Agonists Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Major Buyers of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Distributors/Traders List
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Production and Growth Rate Forecast (2017-2022)
Figure United States Glucagon Like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2017-2022)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Production Forecast by Type (2017-2022)
Table United States Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2017-2022)

COMPANIES MENTIONED

Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin